Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway
Authors
Keywords
Fatty liver, Macrophages, Lipids, Hepatocytes, Glucose, Cholesterol, Inflammation, Steatosis
Journal
PLoS One
Volume 11, Issue 9, Pages e0163667
Publisher
Public Library of Science (PLoS)
Online
2016-09-29
DOI
10.1371/journal.pone.0163667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monounsaturated Fatty Acid–Enriched High-Fat Diets Impede Adipose NLRP3 Inflammasome–Mediated IL-1β Secretion and Insulin Resistance Despite Obesity
- (2015) Orla M. Finucane et al. DIABETES
- Hepatic p38α regulates gluconeogenesis by suppressing AMPK
- (2015) Yanyan Jing et al. JOURNAL OF HEPATOLOGY
- Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
- (2015) V. Ramesh et al. PLoS Neglected Tropical Diseases
- Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice
- (2014) Ana Angélica Amorim Santarem et al. Revista da Sociedade Brasileira de Medicina Tropical
- Direct Comparison of the Efficacy and Safety of Oral Treatments with Oleylphosphocholine (OlPC) and Miltefosine in a Mouse Model of L. major Cutaneous Leishmaniasis
- (2014) Anny Fortin et al. PLoS Neglected Tropical Diseases
- Perifosine inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production via regulation multiple signaling pathways: New implication for Kawasaki disease (KD) treatment
- (2013) Jie Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deletion of Class A Scavenger Receptor Deteriorates Obesity-Induced Insulin Resistance in Adipose Tissue
- (2013) X. Zhu et al. DIABETES
- AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
- (2013) D. G. Hardie DIABETES
- Ursodeoxycholic Acid Inhibits Liver X Receptor α-mediated Hepatic Lipogenesis via Induction of the Nuclear Corepressor SMILE
- (2013) Ji-Min Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondria and AMP-activated Protein Kinase-dependent Mechanism of Efferocytosis
- (2013) Shaoning Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway
- (2013) Zhong Q. Wang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Tissue-resident macrophages
- (2013) Luke C Davies et al. NATURE IMMUNOLOGY
- Anticancer mechanisms and clinical application of alkylphospholipids
- (2012) Wim J. van Blitterswijk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Perifosine sensitizes UVB-induced apoptosis in skin cells: New implication of skin cancer prevention?
- (2012) Chao Ji et al. CELLULAR SIGNALLING
- AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity
- (2012) Joo-Won Lee et al. JOURNAL OF LIPID RESEARCH
- Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: More than just AKT inhibition
- (2011) Hui Sun et al. CANCER LETTERS
- Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
- (2011) Sandra Galic et al. JOURNAL OF CLINICAL INVESTIGATION
- Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Musso et al. Annual Review of Medicine
- AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis
- (2010) Aiping Bai et al. BIOCHEMICAL PHARMACOLOGY
- Macrophage α1 AMP-activated Protein Kinase (α1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1
- (2010) Zhenggang Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models
- (2009) Wolfgang Bäumer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes
- (2009) Kyungmoo Yea et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMPK in Health and Disease
- (2009) Gregory R. Steinberg et al. PHYSIOLOGICAL REVIEWS
- Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury
- (2008) Suresh Varma Penumathsa et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
- (2008) Xiuyun Hou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium
- (2008) S. Varma Penumathsa et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients
- (2008) Elisa Tramentozzi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Lipid rafts, cholesterol, and the brain
- (2008) Zeljka Korade et al. NEUROPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation